Trials / Completed
CompletedNCT03188588
Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- SOS Oxygene Mediterranee · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-01-01
- Completion
- 2020-01-01
- First posted
- 2017-06-15
- Last updated
- 2020-09-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03188588. Inclusion in this directory is not an endorsement.